netupitant/palonosetron; fosnetupitant/palonosetron (Akynzeo)
Jump to navigation
Jump to search
Indications
- treatment of nausea & vomiting associated with chemotherapy
Dosage
- fosnetupitant 235 mg / palonosetron 0.25 mg injection [Akynzeo]
References
- ↑ Calcagnile S1, Lanzarotti C, Rossi G et al Effect of netupitant, a highly selective NK1 receptor antagonist, on the pharmacokinetics of palonosetron and impact of the fixed dose combination of netupitant and palonosetron when coadministered with ketoconazole, rifampicin, and oral contraceptives. Support Care Cancer. 2013 Oct;21(10):2879-87 PMID: https://www.ncbi.nlm.nih.gov/pubmed/23748441
- ↑ Pharmacy News. Oct 14, 2014 Netupitant-Palonosetron Combination Approved by FDA. http://www.ashp.org/menu/News/PharmacyNews/NewsArticle.aspx?id=4118